(Reuters) -Eli Lilly hit $1 trillion in market value on Friday, making it the first drugmaker to enter the exclusive club dominated by tech giants and underscoring its rise as a weight-loss powerhouse.
Here are some reactions to Lilly joining the trillion dollar club:
EVAN SEIGERMAN, ANALYST AT BMO CAPITAL MARKETS
"The current valuation points to investor confidence in the longer-term durability of the company's metabolic health franchise. It also suggests that investors prefer Lilly over Novo in the obesity arms race. Taking a step back, we're also seeing money rotate into the sector as investors may be worried about an AI bubble."
HANK SMITH, DIRECTOR & HEAD OF INVESTMENT STRATEGY AT LILLY SHAREHOLDER HAVERFORD TRUST
"Investors have historically liked secure earnings growth and (Eli Lilly) is the only large cap pharma that has that kind of earnings profile."
(Reporting by Siddhi Mahatole and Shashwat Chauhan in Bengaluru; Editing by Leroy Leo)
LATEST POSTS
- 1
Selena Quintanilla documentary 'Selena y Los Dinos: A Family's Legacy' is coming to Netflix - 26 Well known Nissan Vehicles in the U.S.
- 3The Magnificence of Extraordinariness: Presenting Valuable Adornments and Gemstones
- 46 Natural products High In Vitamins,Which One Do You Like to Eat
- 5US FDA approves Kura-Kyowa's blood cancer therapy
- Iran denies launching ballistic missiles towards Kurdistan region of Iraq
- Selena Quintanilla documentary 'Selena y Los Dinos: A Family's Legacy' is coming to Netflix
- Instructions to Shield Your Gold Speculation from Possible Dangers: Fundamental Protections
- Hubble sees spiral galaxy in Lion's heart | Space photo of the day for Nov. 4
- The Best 15 Applications for Efficiency and Association
- Figure out how to Keep up with Your Dental Inserts for Long haul Achievement
- Deadly heat worldwide prompts $300 million for climate health research at COP30
- 6 Shades Brands For Seniors
- The Best Cell phone Brands for Tech Aficionados
